Transcriptional complementarity in breast cancer: Application to detection of circulating tumor cells

64Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: We used a combination of genetic subtraction, silicon DNA micro-array analysis, and quantitative PCR to identify tissue- and tumor-specific genes as diagnostic targets for breast cancer. Methods and Results: From a large number of candidate antigens, several specific subsets of genes were identified that showed concordant and complementary expression profiles. Whereas transcriptional profiling of mammaglobin resulted in the detection of 70% of tumors in a panel of 46 primary and metastatic breast cancers, the inclusion of three additional markers resulted in detection of all 46 specimens. Immunomagnetic epithelial cell enrichment of circulating tumor cells from the peripheral blood of patients with metastatic breast cancer, coupled with RT-PCR-based amplification of breast tumor-specific transcripts, resulted in the detection of anchorage-independent tumor cells in the majority of patients with breast cancer with known metastatic disease. Conclusion: Complementation of mammaglobin with three additional genes in RT-PCR increases the detection of breast cancers in tissue and circulating tumor cells.

Cite

CITATION STYLE

APA

Houghton, R. L., Dillon, D. C., Molesh, D. A., Zehentner, B. K., Xu, J., Jiang, J., … Reed, S. G. (2001). Transcriptional complementarity in breast cancer: Application to detection of circulating tumor cells. Molecular Diagnosis, 6(2), 79–91. https://doi.org/10.1007/BF03262038

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free